ENTITY

Regencell Bioscience Holdings (RGC US)

Analysis

Health Care • Hong Kong

Regencell Bioscience Holdings Limited operates as a holding company. The Company, through its subsidiaries, focuses on research, development, and commercialization of traditional medicine for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00